Neurim Loses 2nd Bid To Stop Sale Of Rival Drug Brand
A judge rejected on Wednesday a second attempt by drugmaker Neurim to temporarily block rival Teva UK Ltd. from selling its generic version of a melatonin medicine amid a patent dispute....To view the full article, register now.
Already a subscriber? Click here to view full article